000 | 01945 a2200517 4500 | ||
---|---|---|---|
005 | 20250513210034.0 | ||
264 | 0 | _c20000621 | |
008 | 200006s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRatz, J D | |
245 | 0 | 0 |
_aEffects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cMay 2000 |
||
300 |
_a569-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aFlavoproteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aGlutathione _xanalogs & derivatives |
650 | 0 | 4 |
_aIsosorbide Dinitrate _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrosomes _xdrug effects |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNADPH-Ferrihemoprotein Reductase _xmetabolism |
650 | 0 | 4 |
_aNitrates _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitroglycerin _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitroso Compounds _xpharmacology |
650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
650 | 0 | 4 |
_aProdrugs _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aS-Nitrosoglutathione |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 |
_aSuperoxides _xmetabolism |
650 | 0 | 4 |
_aVasodilator Agents _xantagonists & inhibitors |
700 | 1 | _aMcGuire, J J | |
700 | 1 | _aAnderson, D J | |
700 | 1 | _aBennett, B M | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 293 _gno. 2 _gp. 569-77 |
|
999 |
_c10726129 _d10726129 |